AtriCure, Inc. Selling, General and Administrative Expense
AtriCure, Inc. (ATRC) reported Selling, General and Administrative Expense of $82.56 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-27
- AtriCure, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $82.56M, a 5.32% increase year-over-year.
- AtriCure, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $84.55M, a 11.17% increase year-over-year.
- AtriCure, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $78.34M, a 8.53% increase year-over-year.
- AtriCure, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $78.23M, a 6.82% increase year-over-year.
- AtriCure, Inc. selling, general and administrative expense for fiscal 2025 was $311.02M, a 6.75% increase from fiscal 2024.
- AtriCure, Inc. selling, general and administrative expense for fiscal 2024 was $291.36M, a 15.10% increase from fiscal 2023.
- AtriCure, Inc. selling, general and administrative expense for fiscal 2023 was $253.14M, a 9.45% increase from fiscal 2022.
- AtriCure, Inc. selling, general and administrative expense for fiscal 2022 was $231.27M, a 13.01% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $82.56M 10-Q · filed 2026-07-27 | $167.11M 10-Q · filed 2026-07-27 | $245.45M derived: sum of 3 quarters · filed 2026-07-27 | $323.69M derived: sum of 4 quarters · filed 2026-07-27 | ||||
| 2026-03-31 | $84.55M 10-Q · filed 2026-05-06 | $162.89M derived: sum of 2 quarters · filed 2026-05-06 | $241.12M derived: sum of 3 quarters · filed 2026-05-06 | $319.51M derived: sum of 4 quarters · filed 2026-07-27 | ||||
| 2025-12-31 | $78.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $156.57M derived: sum of 2 quarters · filed 2026-02-19 | $234.96M derived: sum of 3 quarters · filed 2026-07-27 | $311.02M 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | $78.23M 10-Q · filed 2025-10-30 | $156.62M derived: sum of 2 quarters · filed 2026-07-27 | $232.68M 10-Q · filed 2025-10-30 | $304.86M derived: sum of 4 quarters · filed 2026-07-27 | ||||
| 2025-06-30 | $78.39M 10-Q · filed 2026-07-27 | $154.44M 10-Q · filed 2026-07-27 | $226.63M derived: sum of 3 quarters · filed 2026-07-27 | $299.87M derived: sum of 4 quarters · filed 2026-07-27 | ||||
| 2025-03-31 | $76.05M 10-Q · filed 2026-05-06 | $148.24M derived: sum of 2 quarters · filed 2026-05-06 | $221.48M derived: sum of 3 quarters · filed 2026-05-06 | $295.07M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $72.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $145.42M derived: sum of 2 quarters · filed 2026-02-19 | $219.02M derived: sum of 3 quarters · filed 2026-02-19 | $291.36M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | $73.24M 10-Q · filed 2025-10-30 | $146.83M derived: sum of 2 quarters · filed 2025-10-30 | $219.17M 10-Q · filed 2025-10-30 | $286.86M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | $73.60M 10-Q · filed 2025-07-30 | $145.94M 10-Q · filed 2025-07-30 | $213.62M derived: sum of 3 quarters · filed 2026-02-19 | $275.23M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | $72.34M 10-Q · filed 2025-04-30 | $140.03M derived: sum of 2 quarters · filed 2026-02-19 | $201.63M derived: sum of 3 quarters · filed 2026-02-19 | $265.41M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | $67.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $129.29M derived: sum of 2 quarters · filed 2026-02-19 | $193.07M derived: sum of 3 quarters · filed 2026-02-19 | $253.14M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $61.60M 10-Q · filed 2024-10-30 | $125.39M derived: sum of 2 quarters · filed 2024-10-30 | $185.45M 10-Q · filed 2024-10-30 | $240.95M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-06-30 | $63.78M 10-Q · filed 2024-07-31 | $123.85M 10-Q · filed 2024-07-31 | $179.35M derived: sum of 3 quarters · filed 2025-02-14 | $236.62M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-03-31 | $60.06M 10-Q · filed 2024-05-02 | $115.56M derived: sum of 2 quarters · filed 2025-02-14 | $172.83M derived: sum of 3 quarters · filed 2025-02-14 | $235.22M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2022-12-31 | $55.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $112.77M derived: sum of 2 quarters · filed 2025-02-14 | $175.16M derived: sum of 3 quarters · filed 2025-02-14 | $231.27M 10-K · filed 2025-02-14 | ||||
| 2022-09-30 | $57.27M 10-Q · filed 2023-11-02 | $119.66M derived: sum of 2 quarters · filed 2023-11-02 | $175.77M 10-Q · filed 2023-11-02 | $229.48M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-06-30 | $62.39M 10-Q · filed 2023-07-26 | $118.50M 10-Q · filed 2023-07-26 | $172.21M derived: sum of 3 quarters · filed 2024-02-16 | $222.09M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-03-31 | $56.12M 10-Q · filed 2023-05-03 | $109.83M derived: sum of 2 quarters · filed 2024-02-16 | $159.70M derived: sum of 3 quarters · filed 2024-02-16 | $216.66M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2021-12-31 | $53.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $103.58M derived: sum of 2 quarters · filed 2024-02-16 | $160.54M derived: sum of 3 quarters · filed 2024-02-16 | $204.65M 10-K · filed 2024-02-16 | ||||
| 2021-09-30 | $49.87M 10-Q · filed 2022-11-02 | $106.83M derived: sum of 2 quarters · filed 2022-11-02 | $150.94M 10-Q · filed 2022-11-02 | $200.61M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $56.96M 10-Q · filed 2022-08-03 | $106.17M 10-Q · filed 2022-08-03 | $150.74M derived: sum of 3 quarters · filed 2023-02-22 | $184.29M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $49.21M 10-Q · filed 2022-05-04 | $93.78M derived: sum of 2 quarters · filed 2023-02-22 | $127.34M derived: sum of 3 quarters · filed 2023-02-22 | $152.24M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $44.57M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $78.13M derived: sum of 2 quarters · filed 2023-02-22 | $103.03M derived: sum of 3 quarters · filed 2023-02-22 | $150.83M 10-K · filed 2023-02-22 | $150.47M 10-K · filed 2021-02-26 | |||
| 2020-09-30 | $33.56M 10-Q · filed 2021-11-04 | $33.75M 10-Q · filed 2020-11-06 | $58.46M derived: sum of 2 quarters · filed 2021-11-04 | $106.26M 10-Q · filed 2021-11-04 | $101.40M 10-Q · filed 2020-11-06 | $153.13M derived: sum of 4 quarters · filed 2022-02-17 | ||
| 2020-06-30 | $24.90M 10-Q · filed 2021-08-05 | $67.65M 10-Q · filed 2021-08-05 | $119.57M derived: sum of 3 quarters · filed 2022-02-17 | $159.85M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-03-31 | $42.75M 10-Q · filed 2021-04-28 | $94.67M derived: sum of 2 quarters · filed 2022-02-17 | $134.95M derived: sum of 3 quarters · filed 2022-02-17 | $172.88M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2019-12-31 | $51.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $92.20M derived: sum of 2 quarters · filed 2022-02-17 | $130.13M derived: sum of 3 quarters · filed 2022-02-17 | $167.14M 10-K · filed 2022-02-17 | $162.23M 10-K · filed 2020-02-24 | |||
| 2019-09-30 | $40.28M 10-Q · filed 2020-11-06 | $78.21M derived: sum of 2 quarters · filed 2020-11-06 | $115.22M 10-Q · filed 2020-11-06 | $147.97M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | $37.93M 10-Q · filed 2020-07-29 | $74.94M 10-Q · filed 2020-07-29 | $107.69M derived: sum of 3 quarters · filed 2021-02-26 | $141.13M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | $37.02M 10-Q · filed 2020-04-30 | $69.76M derived: sum of 2 quarters · filed 2021-02-26 | $103.20M derived: sum of 3 quarters · filed 2021-02-26 | $131.66M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | $32.74M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $66.18M derived: sum of 2 quarters · filed 2021-02-26 | $94.65M derived: sum of 3 quarters · filed 2021-02-26 | $129.52M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $33.44M 10-Q · filed 2019-10-31 | $61.91M derived: sum of 2 quarters · filed 2019-10-31 | $96.78M 10-Q · filed 2019-10-31 | $123.88M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $28.47M 10-Q · filed 2019-07-31 | $63.34M 10-Q · filed 2019-07-31 | $90.44M derived: sum of 3 quarters · filed 2020-02-24 | $120.24M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $34.88M 10-Q · filed 2019-04-26 | $61.97M derived: sum of 2 quarters · filed 2020-02-24 | $91.77M derived: sum of 3 quarters · filed 2020-02-24 | $121.77M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $27.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $56.90M derived: sum of 2 quarters · filed 2020-02-24 | $86.90M derived: sum of 3 quarters · filed 2020-02-24 | $117.00M 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | $29.80M 10-Q · filed 2018-11-02 | $59.80M derived: sum of 2 quarters · filed 2018-11-02 | $89.90M 10-Q · filed 2018-11-02 | $116.63M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-06-30 | $30.00M 10-Q · filed 2018-08-02 | $60.10M 10-Q · filed 2018-08-02 | $86.83M derived: sum of 3 quarters · filed 2019-03-01 | $112.31M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-03-31 | $30.10M 10-Q · filed 2018-04-27 | $56.83M derived: sum of 2 quarters · filed 2019-03-01 | $82.31M derived: sum of 3 quarters · filed 2019-03-01 | $109.75M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2016-12-31 | $26.73M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $52.21M derived: sum of 2 quarters · filed 2019-03-01 | $79.64M derived: sum of 3 quarters · filed 2019-03-01 | $106.42M 10-K · filed 2019-03-01 | ||||
| 2016-09-30 | $25.49M 10-Q · filed 2017-11-02 | $52.92M derived: sum of 2 quarters · filed 2017-11-02 | $79.69M 10-Q · filed 2017-11-02 | $108.10M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-06-30 | $27.43M 10-Q · filed 2017-07-28 | $54.20M 10-Q · filed 2017-07-28 | $82.61M derived: sum of 3 quarters · filed 2018-02-28 | $104.71M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-03-31 | $26.77M 10-Q · filed 2017-05-05 | $55.18M derived: sum of 2 quarters · filed 2018-02-28 | $77.28M derived: sum of 3 quarters · filed 2018-02-28 | $99.35M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2015-12-31 | $28.41M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $50.51M derived: sum of 2 quarters · filed 2018-02-28 | $72.58M derived: sum of 3 quarters · filed 2018-02-28 | $93.85M 10-K · filed 2018-02-28 | ||||
| 2015-09-30 | $22.10M 10-Q · filed 2016-10-28 | $44.17M derived: sum of 2 quarters · filed 2016-10-28 | $65.44M 10-Q · filed 2016-10-28 | $85.65M derived: sum of 4 quarters · filed 2017-03-08 | ||||
| 2015-06-30 | $22.07M 10-Q · filed 2016-08-05 | $43.34M 10-Q · filed 2016-08-05 | $63.55M derived: sum of 3 quarters · filed 2017-03-08 | $78.21M derived: sum of 4 quarters · filed 2017-03-08 | ||||
| 2015-03-31 | $21.27M 10-Q · filed 2016-04-29 | $41.47M derived: sum of 2 quarters · filed 2017-03-08 | $56.13M derived: sum of 3 quarters · filed 2017-03-08 | $73.20M derived: sum of 4 quarters · filed 2017-03-08 | ||||
| 2014-12-31 | $20.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $34.86M derived: sum of 2 quarters · filed 2017-03-08 | $51.93M derived: sum of 3 quarters · filed 2017-03-08 | $73.51M 10-K · filed 2017-03-08 | ||||
| 2014-09-30 | $14.66M 10-Q · filed 2015-10-30 | $31.73M derived: sum of 2 quarters · filed 2015-10-30 | $53.31M 10-Q · filed 2015-10-30 | $70.17M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $17.07M 10-Q · filed 2015-07-31 | $38.65M 10-Q · filed 2015-07-31 | $55.51M derived: sum of 3 quarters · filed 2016-02-29 | $69.57M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $21.58M 10-Q · filed 2015-05-01 | $38.44M derived: sum of 2 quarters · filed 2016-02-29 | $52.50M derived: sum of 3 quarters · filed 2016-02-29 | $66.22M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $16.86M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $30.92M derived: sum of 2 quarters · filed 2016-02-29 | $44.63M derived: sum of 3 quarters · filed 2016-02-29 | $57.01M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $14.06M 10-Q · filed 2014-10-31 | $27.77M derived: sum of 2 quarters · filed 2014-10-31 | $40.16M 10-Q · filed 2014-10-31 | $52.04M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | $13.71M 10-Q · filed 2014-07-30 | $26.09M 10-Q · filed 2014-07-30 | $37.98M derived: sum of 3 quarters · filed 2015-03-02 | $49.15M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | $12.38M 10-Q · filed 2014-04-30 | $24.27M derived: sum of 2 quarters · filed 2015-03-02 | $35.44M derived: sum of 3 quarters · filed 2015-03-02 | $46.59M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $11.89M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $23.06M derived: sum of 2 quarters · filed 2015-03-02 | $34.21M derived: sum of 3 quarters · filed 2015-03-02 | $45.06M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | $11.17M 10-Q · filed 2013-11-01 | $22.32M derived: sum of 2 quarters · filed 2013-11-01 | $33.18M 10-Q · filed 2013-11-01 | $43.65M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2012-06-30 | $11.15M 10-Q · filed 2013-08-02 | $22.00M 10-Q · filed 2013-08-02 | $32.48M derived: sum of 3 quarters · filed 2014-03-11 | $41.68M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2012-03-31 | $10.86M 10-Q · filed 2013-05-03 | $10.86M 10-Q · filed 2012-05-04 | $21.33M derived: sum of 2 quarters · filed 2014-03-11 | $30.54M derived: sum of 3 quarters · filed 2014-03-11 | $40.71M derived: sum of 4 quarters · filed 2014-03-11 | |||
| 2011-12-31 | $10.47M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $19.68M derived: sum of 2 quarters · filed 2014-03-11 | $29.85M derived: sum of 3 quarters · filed 2014-03-11 | $39.87M 10-K · filed 2014-03-11 | $39.87M 10-K · filed 2012-03-12 | |||
| 2011-09-30 | $9.21M 10-Q · filed 2012-11-02 | $9.21M 10-Q · filed 2011-11-04 | $19.38M derived: sum of 2 quarters · filed 2012-11-02 | $29.40M 10-Q · filed 2012-11-02 | $29.40M 10-Q · filed 2011-11-04 | $38.43M derived: sum of 4 quarters · filed 2013-03-08 | ||
| 2011-06-30 | $10.17M 10-Q · filed 2012-08-03 | $10.17M 10-Q · filed 2011-08-05 | $20.19M 10-Q · filed 2012-08-03 | $20.19M 10-Q · filed 2011-08-05 | $29.22M derived: sum of 3 quarters · filed 2013-03-08 | $38.29M derived: sum of 4 quarters · filed 2013-03-08 | ||
| 2011-03-31 | $10.02M 10-Q · filed 2012-05-04 | $19.05M derived: sum of 2 quarters · filed 2013-03-08 | $28.12M derived: sum of 3 quarters · filed 2013-03-08 | $37.36M derived: sum of 4 quarters · filed 2013-03-08 | ||||
| 2010-12-31 | $9.03M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | $18.10M derived: sum of 2 quarters · filed 2013-03-08 | $27.34M derived: sum of 3 quarters · filed 2013-03-08 | $37.05M 10-K · filed 2013-03-08 | $37.05M 10-K · filed 2012-03-12 | |||
| 2010-09-30 | $9.07M 10-Q · filed 2011-11-04 | $18.31M derived: sum of 2 quarters · filed 2011-11-04 | $28.02M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | $9.24M 10-Q · filed 2011-08-05 | $18.95M 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $35.11M 10-K · filed 2012-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |